Location History:
- Rodgau, DE (1995 - 2010)
- Frankfurt-am-Main, DE (2011 - 2015)
Company Filing History:
9 out of 330 
5 out of 6,662 
4 out of 1,829 
Years Active: 1995-2015
Title: Otmar Klingler: Innovator in Pharmacological Compounds
Introduction: Otmar Klingler, based in Rodgau, Germany, is a prolific inventor with an impressive portfolio of 24 patents. His work primarily focuses on the development of innovative compounds that exhibit significant pharmacological activity, particularly in the realm of thrombotic diseases and cardiovascular disorders.
Latest Patents: Among his latest patents are groundbreaking inventions that include cyclic peptides. These compounds, characterized by a specific formula, serve as reversible inhibitors of the interaction between the plasma protein von Willebrand factor and the blood platelet receptor GPIb. This discovery holds potential for the therapy and prevention of athero-thrombotic diseases. Another notable patent involves pyrrole derivatives, which act as P2Y12 antagonists, showcasing a strong anti-aggregating effect on platelets. This invention is aimed at treating thromboembolic disorders and can be utilized in medical conditions that require inhibiting the platelet ADP receptor P2Y12.
Career Highlights: Throughout his career, Otmar Klingler has contributed significantly to the pharmaceutical industry. He has had impactful roles in notable organizations such as Aventis Pharma Deutschland GmbH and Hoechst Aktiengesellschaft. His extensive research and innovative thinking have placed him at the forefront of pharmacological advancements.
Collaborations: Otmar has collaborated with esteemed colleagues, including Gerhard Zoller and Melitta Just. These partnerships have further enriched his work, leading to the successful development of numerous patented compounds that address critical health issues.
Conclusion: Otmar Klingler's contributions to the field of pharmacology through his innovations and patents illustrate the profound impact that dedicated inventors can have on healthcare. His work not only advances scientific knowledge but also opens new avenues for the treatment and prevention of serious medical conditions, benefiting society as a whole.